Here are brokerage firms' views on 7 stocks:
CumminsDeutsche Bank has buy rating with target at Rs 1000 per share as domestic business is seeing continued market share gains. It says exports business finally seems to be seeing an improved activity. Nomura maintains reduce call with target of Rs 690 per share as domestic sales growth remains stable and exports faltered on unsustainably high base from the previous year. Sun PharmaDeutsche Bank reiterates buy rating, with a target price of Rs 900 per share. It says delay in resolving the warning letter at the Halol plant a downside risk. JPMorgan is overweight on stock with target price of Rs 865 per share. Macquarie has outperform rating with target of Rs 1000 per share. It says the company should sustain a premium valuation . ArvindCLSA retain buy call but target is cut to Rs 362 from Rs 366 per share. It says volume-led growth in woven and garments led to beat in textiles revenues. Ashok LeylandCredit Suisse maintains underperform with target of Rs 77 per share. OMCs Nomura has buy rating on stock with target increased to Rs 1635 from Rs 1250 per share. It has buy rating on IOC with target increased to Rs 700 from Rs 540 per share. Nomura has buy rating on BPCL with target increased to Rs 740 from Rs 640 per share. Fortis HealthMacquarie maintains outperform call with target of Rs 250 per share. It says current levels provide an attractive entry point with a 12-month view.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.